Catalyst Wire Dossier Catalyst Wire Dossier

Lusduna

insulin glargine · Merck Sharp & Dohme B.V.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lusduna, covering 2019-01-22 to 2019-01-22. Get the full timeline:

Most recent: EMA Withdrawn: Lusduna (insulin glargine) — Merck Sharp & Dohme B.V.

See pricing